ZYDUSLIFE

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Zydus Lifesciences Limited

Zydus Lifesciences Limited (ZYDUSLIFE) operates in the Healthcare sector, specifically as a Drug Manufacturer - Specialty & Generic. The company engages in the research, developmen...

हिन्दी में

Zydus Lifesciences Limited (ZYDUSLIFE) हेल्थकेयर सेक्टर में एक Drug Manufacturer - Specialty & Generic के रूप में कार्य करती है। कंपनी भारत, संयुक्त राज्य अमेरिका और अंतरराष्ट्रीय ...

₹1,117.5+0.49%1D
Previous trading day close · Data updates after market close
1W: -1.9%
1M: -0.9%
6M: +21.2%
1Y: +13.1%
74/100
GoodResearch Score
Market Cap
₹1.10L Cr
Large Cap
P/E Ratio
22.57
Fair
P/B Ratio
4.32
Premium
ROE
18.7%
Strong
ROCE
25.5%
Excellent
Debt / Equity
0.12
Low debt
Div. Yield
0.1%
EV/EBITDA
13.18
Attractive
52W Low: ₹835.5Current: ₹1,117.552W High: ₹1,232.1
At 71% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
78/100
Growth
Revenue, EPS, profit growth
91/100
Valuation
PE, PB, EV/EBITDA vs sector
57/100
Risk
Debt levels, volatility, coverage
77/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
22.57(Fair)
Forward P/E
27.92(Premium)
P/B Ratio
4.32(Premium)
P/S Ratio
4.11(Good)
EV/EBITDA
13.18(Attractive)
Dividend Yield
0.1%
5Y CAGR
12.3%(Moderate)
Revenue Growth
17.6%(Moderate)
Profitability
ROE
18.7%(Good)
ROCE
25.5%(Excellent)
ROA
13.8%(Efficient)
Net Margin
18.2%(High)
EBITDA Margin
30.6%
Financial Health
Debt to Equity
0.12(Low debt)
Current Ratio
1.89(Healthy)
Quick Ratio
1.45(Good)
Interest Coverage
16.09x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
40(Neutral)
RSI Exp (14)
23(Oversold)
MACD
-1.493(Bearish)
MACD Signal
5.270
BB Position
25%(Middle)
BB Width
11.51%(Normal)
ADX (14)
16.0(Sideways)
Williams %R
-90.5(Oversold)
MFI (14)
53(Neutral)
CCI (20)
-91(Neutral)
Stoch %K
10(Oversold)
ATR (14)
29.93(Avg True Range)
OBV (M)
61.0(Positive)
1W OBV Chg
-3.8%(Decreasing)
Rel Volume
0.36x(Low activity)
Volatility
23.7%(Moderate)
Max DD 1Y
-23.9%(Moderate)
EMA 200
1058.1
EMA 50
1140.4
SMA 200
1017.1
vs SMA 50
-2.3%(Below SMA50)
vs SMA 200
9.9%(Above SMA200)
Volume
5.30L
Avg Vol 3M
14.7L
Shareholding Pattern
Promoter
75.0%
High confidence
FII
6.9%
DII / MF
11.2%
Share ZYDUSLIFE
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.